PhRMA News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

New PhRMA report shows 200 medicines in development for heart disease and stroke - PR Newswire (press release)



PR Newswire (press release)
 
New PhRMA report shows 200 medicines in development for heart disease and stroke 
PR Newswire (press release)
WASHINGTON, Feb. 20, 2018 /PRNewswire-USNewswire/ -- Cardiovascular disease, which includes heart disease and stroke, is the leading cause of death in the United States, accounting for one out of every three deaths. According to the American Heart ...

and more » 


PhRMA points finger at insurers on new drug cost website for consumers - FiercePharma



FiercePharma
 
PhRMA points finger at insurers on new drug cost website for consumers 
FiercePharma
PhRMA wants to keep talking about drug costs. So as part of its ongoing ?Let's Talk About Cost? marketing campaign, the pharma trade organization launched a new consumer-facing website to address the issue and explain the industry's perspective ...

 


PhRMA takes Let's Talk About Cost campaign to the public - Medical Marketing and Media



Medical Marketing and Media
 
PhRMA takes Let's Talk About Cost campaign to the public 
Medical Marketing and Media
WASHINGTON: PhRMA has moved the conversation about drug pricing beyond Washington with a general consumer education version of the Let's Talk About Cost campaign, which launched last year, focused on a DC audience. The campaign includes an interactive ...

and more » 


PhRMA strikes up drug cost conversation - Pharmacy Today, American Pharmacists Association, pharmacist.com



PhRMA strikes up drug cost conversation 
Pharmacy Today, American Pharmacists Association, pharmacist.com
PhRMA strikes up drug cost conversation. Share This Page. January 29, 2018. The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a new website aimed at giving consumers a better understanding of why prescription medications ...

 


Battleground on drug price legislation shifts to states and so does lobbying by PhRMA - MedCity News



MedCity News
 
Battleground on drug price legislation shifts to states and so does lobbying by PhRMA 
MedCity News
It was expected to be a perfunctory statehouse meeting ? three lobbyists and a legislator discussing a proposal to educate Louisiana doctors about the price of drugs they prescribe. The bill seemed like a no-brainer in a country where even decades-old ...

 


Amgen CEO Robert A. Bradway Becomes PhRMA Board Chairman - PR Newswire (press release)



PR Newswire (press release)
 
Amgen CEO Robert A. Bradway Becomes PhRMA Board Chairman 
PR Newswire (press release)
WASHINGTON, Feb. 7, 2018 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) held its board meeting today, officially welcoming three new elected officers. Robert A. Bradway, chairman and CEO, Amgen, became ...

and more » 


PhRMA Criticizes Canada, Korea and Malaysia for 'Onerous and Egregious' IP Practices - Regulatory Focus



Regulatory Focus
 
PhRMA Criticizes Canada, Korea and Malaysia for 'Onerous and Egregious' IP Practices 
Regulatory Focus
PhRMA Criticizes Canada, Korea and Malaysia for 'Onerous and Egregious' IP Practices. Posted 12 February 2018 | By Zachary Brennan. PhRMA Criticizes Canada, Korea and Malaysia for 'Onerous and Egregious' IP Practices. Industry group PhRMA late last ...

 


Amgen CEO named PhRMA board chairman - The Pharma Letter



The Pharma Letter
 
Amgen CEO named PhRMA board chairman 
The Pharma Letter
Mr Bradway was formerly PhRMA's treasurer. He succeeds Joaquin Duato, executive vice president and worldwide chairman for pharmaceuticals at US healthcare giant Johnson & Johnson (NYSE: JNJ). PhRMA president and chief executive, Stephen Ubl, said: ?I ...

 


Pharma lobbyists flood state capitols to fend off drug-pricing action - FiercePharma



FiercePharma
 
Pharma lobbyists flood state capitols to fend off drug-pricing action 
FiercePharma
No one expected the industry scrum that materialized. About 10 pharma lobbyists flooded the room in Baton Rouge's art deco state Capitol, some of them hired guns?lobbyists who'd never represented drug companies before?remembers Jeff Drozda, an ...

and more » 


Axing Restasis Patents Would Stifle Innovation, PhRMA Warns - Law360



Axing Restasis Patents Would Stifle Innovation, PhRMA Warns 
Law360
Axing Restasis Patents Would Stifle Innovation, PhRMA Warns. By Dani Kass. Law360, New York (January 31, 2018, 8:40 PM EST) -- The Pharmaceutical Research and Manufacturers of America on Wednesday warned the Federal Circuit that allowing a district ...